Aortic stenosis trials in Australia
8 of 10 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in AustraliaValidation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
- Where
- Chermside, Clayton, Melbourne, Murdoch, Newcastle, Sydney
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT07696182 - No phaseTaking peopleTrial of the F2 Filter and Delivery System for Embolic Protection During TAVR
- Where
- Clayton, Spring Hill
- Age
- 21 years to 90 years
- People
- 500 worldwide
- Run by
- EnCompass Technologies, Inc.
See details and how to joinNCT06689839 - No phaseTaking peopleALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
- Where
- Adelaide, Parkville, Spring Hill
- People
- 1,234 worldwide
- Run by
- Edwards Lifesciences
See details and how to joinNCT05172960 - No phaseEnrolling by invitationENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
- Where
- Adelaide, Clayton, Melbourne, Newcastle
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT05932615 - No phaseTaking peopleThe Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
- Where
- Adelaide, Chermside, Clayton, Douglas, Elizabeth Vale, Epping, Garran, Geelong, Hobart, Kingswood, Liverpool, New Lambton Heights, Perth, Southport, St Leonards, Tiwi, Westmead, Wollongong
- Age
- 18 years and over
- People
- 2,104 worldwide
- Run by
- University of Leicester
See details and how to joinNCT04204915 - No phaseNot yet taking people in AustraliaDilation Optimisation for Uniform Bioprosthetic Leaflet Expansion
- Where
- Malvern, Melbourne, Richmond
- Age
- 18 years and over
- People
- 250
- Run by
- The Alfred
See details and how to joinNCT07430267 - No phaseTaking peoplePROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- Where
- Adelaide, Bedford Park, Chermside, Clayton
- Age
- 65 years and over
- People
- 2,250 worldwide
- Run by
- Edwards Lifesciences
See details and how to joinNCT04889872 - No phaseTaking peopleClinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
- Where
- Clayton
- Age
- 18 years and over
- People
- 30
- Run by
- Transverse Medical, Inc.
See details and how to joinNCT06962371